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Abstract
Background: This study examined how ethnic differences in sleep and depression were related
to environmental illumination and circadian rhythms.
Methods: In an ancillary study to the Women's Health Initiative, 459 postmenopausal women
were recorded for one week in their homes, using wrist monitors. Sleep and illumination
experience were estimated. Depression was self-rated with a brief adjective check list. Affective
diagnoses were made using the SCID interview. Sleep disordered breathing was monitored with
home pulse oximetry.
Results:  Hispanic and African-American women slept less than European-American women,
according to both objective recordings and their own sleep logs. Non-European-American women
had more blood oxygen desaturations during sleep, which accounted for 26% of sleep duration
variance associated with ethnicity. Hispanic women were much more depressed. Hispanic, African-
American and Native-American women experienced less daily illumination. Less daily illumination
experience was associated with poorer global functioning, longer but more disturbed sleep, and
more depression.
Conclusions:  Curtailed sleep and poor mood were related to ethnicity. Sleep disordered
breathing was a factor in the curtailed sleep of minority women. Less illumination was experienced
by non-European-American women, but illumination accounted for little of the contrasts between
ethnic groups in sleep and mood. Social factors may be involved.
Background
Sleep disturbances and depression seem particularly
prominent among postmenopausal women. There has
been little explanation of the apparently-more-severe
sleep disturbances among minorities, though one factor
appears to be obesity influencing sleep disordered breath-
ing [1-5]. Data on ethnic differences in depression have
been mixed. The National Comorbidity Survey Replica-
tion found the 12-month odds ratio for major depressive
disorder as 1.3 (0.8–2.2 95% C.I.) for non-Hispanic
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Blacks and 1.6 (1.0–2.6 95% C.I.) for Hispanics as com-
pared to non-Hispanic Whites; however, the lifetime prev-
alences for the minorities were not elevated [6]. NHanes
III found more major depression among Whites than
among Blacks and Mexican Americans ages 17–39 years,
but dysthymia was greater among Blacks and Mexican
Americans [7]. For ages 54–65, the Health and Retirement
Survey found more major depression among African
Americans (OR = 1.44, 95% C.I. = 1.02–2.04) and His-
panics (OR-1.16, 95% C.I. = 0.93–1.44) than among
Whites, but these odds ratios dropped below 1.0 when
adjusted for sociodemographic, health, and economic
covariates [8]. Thus, age, social factors, and diagnostic per-
spectives seem to complicate ethnic contrasts in
depression.
The complex causal inter-relationships of illumination,
sleep disturbances, depression, circadian rhythms, and
general health have been difficult to resolve. Each of these
factors might be influenced by aging, by ethnic factors,
and by social factors related to ethnicity. Previously, our
group found that low daily illumination was associated
with both greater depressive symptoms and greater sleep
complaints in the population as a whole [9,10]. Bright
light treatment has been an effective treatment of depres-
sion in short-term studies of both nonseasonal and sea-
sonal depression [11,12], but long-term studies are
lacking. None of the controlled light treatment trials for
nonseasonal depression have included sleep recording.
Bright light has been recommended for treatment of vari-
ous sleep disorders [13], but very few experimental trials
have been reported. It is known that illumination may
influence circadian adjustment, and conversely, circadian
adjustment (especially the time of arising) may influence
a person's exposure to daylight. Without artificial bright
light treatment, wellness and energy influencing time out-
doors in daylight may be major factors influencing daily
light exposure. Light may have a causal role in depression,
but depression could also influence how much people
expose themselves to bright daylight. Sleep disturbances
and circadian adjustment may influence either depression
or general wellness and vice versa.
This study examined ethnic differences in sleep and
depression to explore how environmental illumination
and circadian rhythms might interact with sleep, depres-
sion, and ethnicity. Extensive home recordings for this
study were analyzed here to see how ethnicity, illumina-
tion, sleep, and mood each was associated with the other
factors with which they might causally interact. The con-
tribution of sleep disordered breathing was also consid-
ered. The cross-sectional methodology was capable of
exploring the strength of associations but was not capable
of distinguishing causal pathways.
Methods
The current study analyzed the baseline data of a prospec-
tive study organized to explore whether objectively-meas-
ured sleep durations predict mortality. From among
volunteers in the Observational Study enrolled at the San
Diego Vanguard Clinical Center for the Women's Health
Initiative [14], 459 postmenopausal women were
recruited to participate in this ancillary study. This was not
a representative population sample. Recruitment focused
on subjects with particularly short or long reported sleep,
older age, and minority ethnicity from within the larger
group of volunteers for the Women's Health Initiative.
Each subject signed written informed consent under
supervision of UCSD's Institutional Review Board, con-
sistent with the World Medical Association Declaration of
Helsinki. Results from melatonin measurements and
SCID psychiatric interviews of these women and some
aspects of their sleep data have been described elsewhere
[15-20].
Each woman wore an Actillume I wrist monitor (Ambula-
tory Monitoring, Ardsley, New York) for up to one week.
The Actillume included a linear accelerometer and a pho-
tometric transducer used to continuously measure the
illumination experienced in lux. From accelerometer indi-
cations of wrist activity, in-bed sleep-wake state was esti-
mated for one-minute epochs, using a validated computer
algorithm, supplemented by "Webster's rules" [21] and
hand-editing, e.g., to delete epochs when the device was
removed for bathing. "Webster's rules" improve the spe-
cificity of scoring of out-of-bed sleep and the accuracy of
24-hour sleep scoring at the expense of over-estimating
the amount of wake within sleep. In post-menopausal
women, with this scoring method, actigraphic total sleep
time correlated r = 0.97 with polysomnographic scoring,
but there was a mean underestimation of EEG sleep time
of about 30 minutes [21]. The objective in-bed nocturnal
sleep durations were averaged for a mean of 6.8 nights
(SD 0.6) per subject. The log [base 10] of Actillume lux
measurements was used as the measure of experienced
illumination, since biological effects of illumination (in
shifting circadian phase or suppressing melatonin, for
example) may be roughly linear to the log of illumination
along the central portion of a sigmoid dose-response
curve [22,23]. Values of less than 1 lux were set to
log10[lux] = 0, to avoid giving weight to very small varia-
tions in illumination which may lack physiologic effect. A
24-hour cosine was fit to the week's measurements, to cor-
rect for time-of-day biases in missing data, and the mesor
(fitted cosine's mean) was employed as the best estimate
of daily illumination.
For several nights during the study, the women wore a
VX4 finger pulse oximeter, but many recordings were lost
due to technical problems, especially intermittent failuresBMC Psychiatry 2004, 4 http://www.biomedcentral.com/1471-244X/4/8
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of VX4 instruments. Valid data were available for at least
one night for 358 women. Of these, there were data for 2
nights for 80%, for 3 nights for 44%, and for 4 nights for
3%. The oxygen desaturation index 4% or ODI4 was com-
puted as the number of oxygen desaturations of ≥4% per
hour of sleep, averaged over the available nights. The
ODI4 is very highly correlated with the respiratory distur-
bance index, the most validated indicator of sleep disor-
dered breathing [24]. The oximetry methodology had the
advantage of facilitating multi-night assessment of sleep
disordered breathing in the home setting.
Daily sleep-log reports of subjective sleep duration were
averaged for the recording week. At the end of the week,
the 10-item sleep questionnaire used at Women's Health
Initiative intake [3] was readministered to measure sub-
jective sleep quality, trouble falling asleep, waking up sev-
eral times a night, waking up earlier than planned, and
trouble getting back to sleep. At the end of the recording
week, subjects also completed a brief mood scale which
included 6 items from the CES-D [25]. To avoid con-
founding sleep complaints with depression, the item
about restless sleep was removed, leaving 5 items.
Although this scale has only modest validity [19], it served
as a general indicator of the degree to which the subjects
were depressed at the moment. Affective diagnoses and
ratings of Global Assessment of Functioning were
obtained from SCID interviews [26] conducted by DFK,
usually within 2 weeks of the recordings.
Subjects provided around-the-clock fractional urine spec-
imens for analysis of 6-sulfatoxymelatonin (aMT6s), the
major urinary metabolite of melatonin, as described pre-
viously [27]. Most subjects provided urine specimens for
two 24-hour intervals during the week of actigraphic
recording. From these assays, timing and volume data, it
was possible to estimate total daily melatonin production
and the parameters of the circadian rhythm of melatonin
excretion.
Participants self-identified their ethnicity as European-
American (White), Hispanic (or Latino) regardless of race,
African-American (Black), Asian (or Pacific Islander), and
Native-American (or Aleut). Analyses of covariance
(ANCOVA) were used to determine the influence of eth-
nicity (5 levels) as a fixed factor, as well as various covari-
ates, especially age, education, and illumination. Also, in
order to assess the strength of associations, partial correla-
tions were calculated, using presence or absence of each
ethnic group as a pseudo-variable for control. Supplemen-
tary rank-order correlations were used for skewed data.
Results
Of 459 women who participated in the study, because of
missing data items, only 416–450 could be included in
most analyses (300–350 for ODI4 analyses). Their ages
averaged mean (SD) 67.7 (7.9) years overall, but the Euro-
pean-Americans averaged 70 years of age, whereas each of
the four non-European groups averaged 62 years of age (p
< 0.001), as shown in Table 1. Their mesor of log10[lux]
illumination had a mean (SD) of 1.10 (0.27) with a range
from 0.11 to 2.12. This corresponds to over a hundred-
fold range of daily illumination experienced. Objective in-
bed sleep averaged (SD) 360 min. (55), without correct-
ing for the likely 30 min. underestimation due to acti-
graphic scoring. Sleep log reported sleep times averaged
412 min. (60), and their sleep had averaged 408 min. (69)
in estimates of typical sleep for the past 4 weeks recorded
at intake to the WHI program. The correlation of objective
and sleep log sleep times was r = 0.51 (p < 0.001). Thirty
of the women were diagnosed as having a major or minor
depressive disorder at the time of the study by SCID inter-
views. On the 5 CES-D items, the mean (SD) score was 1.0
(1.9), indicating a highly skewed distribution, with over
half the women reporting no mood symptoms.
To examine factors related to depression, ethnicities were
contrasted. The depression scores adjusted for education
and mesor log10[lux] were more than twice as high among
Hispanics as among European-American women, as
shown in Table 2 (p < 0.001). Age was not related to
mood in this analysis. Similarly, 13% of Hispanic women
received a SCID diagnosis of a current mood disorder as
compared to 6% of European-Americans (p < 0.05). Illu-
Table 1: Demographics of 5 ethnic groups: means (95% confidence intervals)




Percentage of Sample 72.2% 13.7% 9.4% 4.0% 0.7%
Age 69.8 (69.1–70.6) 62.4 (60.6–64.2) 61.7 (59.4–64.0) 61.7 (58.0–65.5) 62.3 (48.8–75.8)
Education (~years) 14.6 (14.4–15.0) 13.0 (12.0–14.0) 14.4 (13.4–15.4) 15 (13.6–16.4) 13.4 (9.8–16.8)
Body Mass Index 26.5 (25.7–27.2) 28.0 (26.5–29.6) 30.3 (28.3–32.4) 23.3 (21.6–25.0) 29.8
Employed 16% (12%–21%) 43% (30%–56%) 46% (31%–62%) 50% (25%–75%) 100%
Currently Married 60% (55%–65%) 62% (50%–75%) 57% (42%–72%) 78% (58%–98%) 67% (1–100%)
Current smoking 7% (3%–11%) 19% (5%–33%) 29% (11%–48%) 0% 0%BMC Psychiatry 2004, 4 http://www.biomedcentral.com/1471-244X/4/8
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mination was a significant covariate (p < 0.025) of mood
scores. The simple Spearman correlation of illumination
and depression symptoms was rS = -0.14 (p < 0.005). The
partial correlation of depression symptoms with illumina-
tion was rp = -0.11 (p = <0.025), controlling for age, edu-
cation, and ethnicity. However, controlling also for
income reduced rp to -0.08 (NS). The partial correlation of
illumination with the presence of any SCID mood disor-
der was low: rp = -0.08 (NS).
The SCID global assessment of functioning scale was not
significantly impacted by ethnicity, with covariates of age,
education, and illumination exposure in the model. How-
ever, the covariates were all highly significant (p < 0.001).
Adding income as a covariate for global assessment of
functioning did not substantially change these results. The
partial correlation of illumination with the SCID global
assessment of functioning, controlling for age, education,
and ethnicity, was rp = 0.22 (p < 0.001), but adding con-
trol for income reduced the partial correlation to rp = 0.16
(p < 0.001).
Neither the mood scale nor SCID diagnoses of depression
were significantly correlated with objective sleep dura-
tion. There was a trend for more depressed mood to be
associated with both the shortest and longest sleep dura-
tions, but this was not significant.
Controlling for age and education in ANCOVA, ethnicity
was significantly related to mesor log10[lux] illumination
exposure (p < 0.001) as shown in Table 2. These log10[lux]
values indicated that European Americans received twice
the daily illumination as Native Americans on a linear
scale.
As detailed in Table 2, objective sleep time was signifi-
cantly related to ethnicity (p < 0.001) in ANCOVA con-
trolled for covariates of illumination (p < 0.001), age
(NS), education (NS), and depression score (NS). From
another viewpoint, the partial correlation of objective
sleep duration with mesor log10[lux] was rp = -0.20 (p <
0.001), controlling for age and controlling for ethnicity
coded as pseudovariables. That is, those experiencing
more illumination slept less. Further adjustment for
mood scores or presence of SCID depression did not sub-
stantially alter this partial correlation. Melatonin excre-
tion (aMT6s log10[mesor]), estimated nightly duration of
excretion, offset timing, and acrophase deviation were not
significant covariates of objective sleep duration when
included in the ANCOVA model. Although ethnicity was
likewise related to sleep-log-reported sleep durations (p <
0.001), illumination, education, and age were not signifi-
cant covariates. The timing (acrophase) of sleep was influ-
enced by ethnicity (p < 0.01), mesor log10[lux] (p <
0.005), and the timing (acrophase) of light (p < 0.05), but
education and age were not significant covariates. The par-
tial correlation of mesor log10[lux] with the acrophase of
sleep was rp= -0.14 (p < 0.005), controlling for age and
ethnicity, indicating that those who received more daily
illumination went to bed and awakened earlier. Out-of-
bed (daytime) sleep was not significantly related to eth-
nicity or illumination.
In partial correlations controlling for age and ethnicity,
sleep-log-reported sleep durations were positively corre-
lated with subjective sleep quality (rp = 0.27, p < 0.001),
and negatively correlated with reported trouble falling
asleep (rp= -0.28, p < 0.001), waking up several times a
night (rp= -0.11, p < 0.025), waking up earlier than
planned (rp= -0.30, p < 0.001), and trouble getting back to
sleep (rp = -0.36, p < 0.001). Although mesor log10[lux]
was not significantly correlated with sleep-log sleep dura-
tions, it was similarly positively correlated with sleep
quality (rp = 0.17, p < 0.005), and negatively correlated
with reported trouble falling asleep (rp= -0.17, p < 0.005),
waking up several times a night (rp= -0.18, p < 0.001),
waking up earlier than planned (rp= -0.09, p < 0.10), and
trouble getting back to sleep (rp = -0.11, p < 0.025). As
would be expected, depression symptoms and the pres-
ence of a SCID mood disorder had significant inverse
relationships to subjective sleep quality and positive asso-
ciations with subjective sleep complaints (details not pre-
sented.) Melatonin excretion (aMT6s log10[mesor]) was
Table 2: Covariate-adjusted mean measures for ethnic groups (95% confidence intervals)




Depression score 0.91 (0.69–1.12) 2.14 (1.64–2.71) 0.56 (0–1.19) 1.01 (0.14–1.88) 0 (0–1.75)
mesor log10[lux] 1.14 (1.11–1.17) 0.98 (0.92–1.05) 0.94 (0.86–1.03) 1.11 (0.98–1.23) 0.83 (0.54–1.12)
objective sleep (min.) 369 (362–375) 350 (334–365) 315 (297–333) 341 (316–365) 357 (303–423)
subjective sleep (min.) 418 (411–425) 395 (379–411) 378 (360–397) 421 (395–448) 388 (324–453)
acrophase of sleep 2:59 (2:52–3:06) 2:43 (2:26–3:00) 2:57 (2:37–3:18) 3:48 (3:19–4:17) 2:38 (1:28–3:53)
ODI4 8.8 (7.6–10.0) 11.4 (8.4–14.3) 12.4 (9.1–15.8) 13.7 (8.2–19.2) 31.1 (12.6–49.6)BMC Psychiatry 2004, 4 http://www.biomedcentral.com/1471-244X/4/8
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not significantly related to sleep symptoms or quality,
with control for age and ethnicity.
The ODI4 range in these women was 0 to 57 desaturations
per hour: the 75th percentile was 12, and the 90th percen-
tile was 21. Oxygen desaturations were substantially
related to ethnicity, in ANCOVA controlled for age and
education (p < 0.025). Table 2 gives the adjusted ODI4
means by ethnicity. Although body mass index correlated
substantially with ODI4 (Spearman rs = 0.28, p < 0.001),
adjustment for body mass index had little effect on ethnic
differences. ODI4 was negatively correlated with acti-
graphic sleep duration (rp= -0.28, p < 0.001). Testing the
ethnicity effect on sleep duration in ANCOVA controlled
for age, education, and illumination, adjusting for ODI4
reduced by 26% the sum of squares explained by ethnicity
(p < 0.001). ODI4 was weakly positively correlated with
subjective wake after sleep onset (rp = 0.11, p < 0.05).
ODI4 was not significantly correlated with subjective
sleep duration, sleep quality, trouble falling asleep, wak-
ing early, or trouble getting back to sleep, nor with depres-
sion, Global Assessment of Functioning, or illumination.
In ANCOVA, aMT6s log10[mesor] was not related to eth-
nicity or illumination but decreased significantly with age
(p < 0.001). The timing of the melatonin excretion acro-
phase and offset were both related to log10[lux] in partial
correlations controlled for age and ethnicity with rp= -0.14
(p < 0.025), i.e., the brighter the illumination, the earlier
the aMT6s acrophase and offset. Melatonin onset time
was not significantly related.
Discussion
In this sample, Hispanic and African-American women
reported that they slept less than European-American
women, reporting subjective sleep durations quite similar
to that of the larger national WHI sample [3]. This con-
trast was confirmed by the objective recordings. A limita-
tion of the results is that recruiting for women with
particularly short or long sleep could have biased the
means for ethnic groups. Although the actigraphic scoring
algorithm may underestimate nocturnal EEG sleep by an
average of 30 min. [21], these data still confirm other
studies showing that objective sleep duration is often less
than the sleep duration that people report. This is proba-
bly because people do not subtract from their reported
sleep durations all of their wake after sleep onset.
Sleep apnea was one of the sources of reduced sleep in
non-European women. As has been previously described
[28], sleep apnea is pervasive in this age group. ODI4 val-
ues were substantially higher in non-European women.
Since sleep apnea is often thought to be associated with
excessive sleep, it was surprising that ODI4 was associated
with shorter sleep but not otherwise much related to sleep
symptomatology, depression, or disability. It has been
repeatedly shown that the ODI4 is a very reliable correlate
of respiratory disturbance indexes derived from full poly-
somnography [24]. Additional reliability in these record-
ing results from the multiple ODI4 recording nights for
most women included in the ODI4 analyses. Community
samples with both actigraphic and polysomnographic
technologies have found more modest associations of
symptomatology with sleep disordered breathing than
have samples derived from sleep clinics [24,29,30].
As has been previously noted in larger portions of the
WHI sample [14], Hispanic postmenopausal women
reported markedly more depression. This was confirmed
by the SCID interviews [27]. The reasons for poor sleep
and poor mood among non-European women have not
been immediately apparent. Social and cultural influences
could be factors, both in the development of depression
and in expressiveness of symptoms. A higher risk ratio for
12-month depression was found among Hispanics in the
National Comorbidity Study replication (1.6, 95% CI
1.0–2.6), but was not separated by gender [31]. No linear
correlations were noted between sleep duration and the
indices of depression. A U-shaped relationship of depres-
sion to both long and short self-reported sleep was evi-
dent in the national Women's Health Initiative sample
[3]; there was a similar trend in these data but no signifi-
cant relationship.
Low daily illumination was weakly associated with
depressed mood. Hispanic women experienced lower illu-
mination, but in ANCOVA models, controlling for illumi-
nation eliminated only 12% of the variance in depression
attributable to ethnicity. It is plausible that low illumina-
tion was a source of depressed mood, but the converse
would also be plausible. That is, depression might influ-
ence women to spend less time outdoors in daylight. The
more substantial correlation of illumination with the glo-
bal assessment of functioning may be consistent with the
hypothesis that poor functioning causes poor illumina-
tion experience which then may contribute to depression,
perhaps engendering a circular process. Low illumination
experience might also be a contributing cause to the poor
global function with which it was associated. It is plausi-
ble that income directly affects global function, as func-
tional ability no doubt affects income, but income may
also influence global functioning indirectly through illu-
mination experience, e.g., a wealthy woman with a home
garden and a golf club membership might experience
more daylight than a woman of modest means living in
an apartment.
Since illumination was negatively correlated with objec-
tive sleep duration (those experiencing less illumination
slept slightly longer), low illumination provided no expla-BMC Psychiatry 2004, 4 http://www.biomedcentral.com/1471-244X/4/8
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nation for the abbreviated sleep of non-European women.
Nevertheless, those experiencing lower illumination
reported more complaints about sleep such as poor sleep
quality, trouble falling asleep, waking up several times a
night, waking up earlier than planned, etc. These com-
plaints may result from low mood, with which they were
associated, or even from spending too long a time in bed.
Low illumination may well contribute to the distress
engendering sleep complaints.
It appears that women who experienced more illumina-
tion arose somewhat earlier. Increased illumination may
tend to advance the circadian system, but the converse
that those who arise early may receive more outdoor illu-
mination is also plausible. Similarly, those experiencing
more illumination had a somewhat more advanced mela-
tonin rhythm, possibly in part due to suppression of
melatonin by morning light and in part due to a phase
advance of the circadian clock. Nevertheless, as reported
elsewhere, the amount of melatonin excreted was not
related to sleep symptoms, duration, or quality, nor could
melatonin account for ethnic differences in sleep.
In conclusion, low-illumination has a small relationship
to depression and sleep disturbances, but it accounted for
little of the poor sleep and low mood of non-European
postmenopausal women. Sleep disordered breathing
appears to abbreviate sleep in non-European women, but
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